LABU vs. AGQ
LABU (Direxion Daily S&P Biotech Bull 3x Shares) and AGQ (ProShares Ultra Silver) are both exchange-traded funds - LABU is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (300%), while AGQ is a Silver fund tracking the Bloomberg Silver Subindex (200%). Both are passively managed. Over the past 10 years, LABU returned -11.11%/yr vs 8.24%/yr for AGQ. At a 0.13 correlation, their price movements are largely independent. LABU charges 1.12%/yr vs 0.93%/yr for AGQ.
Performance
LABU vs. AGQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABU achieves a 12.06% return, which is significantly higher than AGQ's -41.54% return. Over the past 10 years, LABU has underperformed AGQ with an annualized return of -11.11%, while AGQ has yielded a comparatively higher 8.24% annualized return.
LABU
- 1D
- 2.37%
- 1M
- -8.14%
- YTD
- 12.06%
- 6M
- 8.94%
- 1Y
- 198.09%
- 3Y*
- 6.07%
- 5Y*
- -34.35%
- 10Y*
- -11.11%
AGQ
- 1D
- 1.44%
- 1M
- -42.34%
- YTD
- -41.54%
- 6M
- -27.69%
- 1Y
- 86.62%
- 3Y*
- 45.61%
- 5Y*
- 11.26%
- 10Y*
- 8.24%
LABU vs. AGQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 12.06% | 79.17% | -26.02% | -13.41% | -80.36% | -64.15% | 74.66% | 75.50% | -57.61% | 149.12% |
AGQ ProShares Ultra Silver | -41.54% | 360.71% | 23.92% | -15.09% | -7.89% | -32.25% | 62.02% | 20.02% | -22.10% | 5.49% |
Correlation
The correlation between LABU and AGQ is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since May 28, 2015 | 0.13 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABU vs. AGQ — Risk / Return Rank
LABU
AGQ
LABU vs. AGQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and ProShares Ultra Silver (AGQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LABU | AGQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.86 | ||
| Sortino ratioReturn per unit of downside risk | +1.27 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.27 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 6.49 | 1.09 | +5.40 |
| Martin ratioReturn relative to average drawdown | 18.31 | 2.07 | +16.23 |
Loading charts...
Drawdowns
LABU vs. AGQ - Drawdown Comparison
The maximum LABU drawdown since its inception was -99.18%, roughly equal to the maximum AGQ drawdown of -98.16%. Use the drawdown chart below to compare losses from any high point for LABU and AGQ.
Loading charts...
Drawdown Indicators
| LABU | AGQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.18% | -98.16% | -1.02% |
Max Drawdown (1Y)Largest decline over 1 year | -30.70% | -79.89% | +49.19% |
Max Drawdown (3Y)Largest decline over 3 years | -78.30% | -79.89% | +1.59% |
Max Drawdown (5Y)Largest decline over 5 years | -97.59% | -79.89% | -17.70% |
Max Drawdown (10Y)Largest decline over 10 years | -98.96% | -79.89% | -19.07% |
Current DrawdownCurrent decline from peak | -96.05% | -87.59% | -8.46% |
Average DrawdownAverage peak-to-trough decline | -81.69% | -79.85% | -1.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.91% | 41.95% | -31.04% |
Volatility
LABU vs. AGQ - Volatility Comparison
The current volatility for Direxion Daily S&P Biotech Bull 3x Shares (LABU) is 31.31%, while ProShares Ultra Silver (AGQ) has a volatility of 33.96%. This indicates that LABU experiences smaller price fluctuations and is considered to be less risky than AGQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABU | AGQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 31.31% | 33.96% | -2.65% |
Volatility (6M)Calculated over the trailing 6-month period | 61.52% | 135.10% | -73.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.69% | 122.60% | -44.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 95.70% | 75.28% | +20.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.45% | 65.96% | +29.49% |
LABU vs. AGQ - Expense Ratio Comparison
LABU has a 1.12% expense ratio, which is higher than AGQ's 0.93% expense ratio.
Dividends
LABU vs. AGQ - Dividend Comparison
LABU's dividend yield for the trailing twelve months is around 0.69%, while AGQ has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
AGQ ProShares Ultra Silver | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.69% | 0.84% | 0.35% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
Frequently Asked Questions
LABU and AGQ have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AGQ has higher volatility (33.96%) compared to LABU (31.31%). In terms of maximum drawdown, LABU dropped -99.18% vs AGQ's -98.16%.
On 10-year performance, AGQ leads with 8.24% vs -11.11% for LABU. On fees, AGQ is cheaper at 0.93% per year. On volatility, LABU has been the lower-risk option at 31.31%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, AGQ has performed better with a 8.24% return vs -11.11%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
AGQ is cheaper with a 0.93% expense ratio, compared with 1.12% for LABU.
LABU has the higher dividend yield at 0.69%, compared with 0.00% for AGQ.
LABU is categorized as Leveraged Equities, while AGQ is Silver. LABU tracks S&P Biotechnology Select Industry Index (300%), while AGQ tracks Bloomberg Silver Subindex (200%). They also come from different issuers: Direxion and ProShares. Their fees differ too: 1.12% for LABU and 0.93% for AGQ.
LABU currently has the higher Sharpe Ratio (2.57 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABU and AGQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer